Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise (Q38876402)

7 September 2017

Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise (English)

1 reference

7 September 2017

Qian Chen

1

1 reference

PubMed ID

27111654

7 September 2017

Zhuang Liu

series ordinal

2

1 reference

PubMed ID

27111654

7 September 2017

language of work or name

English

0 references

publication date

25 April 2016

1 reference

7 September 2017

1 reference

7 September 2017

28

1 reference

7 September 2017

47

1 reference

7 September 2017

10557-10566

1 reference

Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy

7 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Human serum albumin: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Albumin-drug interaction and its clinical implication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Albumin-based nanoparticles as potential controlled release drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Physicochemical and immunological assessment of engineered pure protein particles with different redox states

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

In vivo architectonic stability of fully de novo designed protein-only nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Imaging and drug delivery using theranostic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Theranostic nanoshells: from probe design to imaging and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Nanoscale theranostics for physical stimulus-responsive cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Theranostics: combining imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

The advancement of human serum albumin-based molecular probes for molecular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Dye-loaded ferritin nanocages for multimodal imaging and photothermal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Albumin as a versatile platform for drug half-life extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Chimeric ferritin nanocages for multiple function loading and multimodal imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Self-assembly of ibuprofen and bovine serum albumin-dextran conjugates leading to effective loading of the drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Characterization of subdomain IIA binding site of human serum albumin in its native, unfolded, and refolded states using small molecular probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Paclitaxel-HSA interaction. Binding sites on HSA molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

The preparation and characterization of folate-conjugated human serum albumin magnetic cisplatin nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Characterization of site I on human serum albumin: concept about the structure of a drug binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Drug-protein binding. IV. Modulation of binding. Increasing activity of sulfonamides with displacing agents: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Binding of Drugs by Albumin Plasma Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Binding and circular dichroism data on bilirubin-albumin in the presence of oleate and salicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Structural basis of the drug-binding specificity of human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Docetaxel-albumin conjugates: preparation, in vitro evaluation and biodistribution studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Supramolecular adducts of squaraine and protein for noninvasive tumor imaging and photothermal therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

An albumin-based theranostic nano-agent for dual-modal imaging guided photothermal therapy to inhibit lymphatic metastasis of cancer post surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Near-infrared dye bound albumin with separated imaging and therapy wavelength channels for imaging-guided photothermal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Plasmonic photothermal therapy (PPTT) using gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Protein-based photothermal theranostics for imaging-guided cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Photodeposition of silver can result in metal-enhanced fluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Impact of nanotechnology on drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Targeted albumin-based nanoparticles for delivery of amphipathic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

An imagable and photothermal "Abraxane-like" nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

89Zr-nanocolloidal albumin-based PET/CT lymphoscintigraphy for sentinel node detection in head and neck cancer: preclinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

In vivo photoacoustic molecular imaging with simultaneous multiple selective targeting using antibody-conjugated gold nanorods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Photoacoustic imaging in biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

A Self-Assembled Albumin-Based Nanoprobe for In Vivo Ratiometric Photoacoustic pH Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Luminescent properties of water-soluble denatured bovine serum albumin-coated CdTe quantum dots.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Protein-passivated Fe(3)O(4) nanoparticles: low toxicity and rapid heating for thermal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Protein/Polymer-Based Dual-Responsive Gold Nanoparticles with pH-Dependent Thermal Sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Protein-directed synthesis of highly fluorescent gold nanoclusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Multistimuli-Regulated Photochemothermal Cancer Therapy Remotely Controlled via Fe5C2 Nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Protein modified upconversion nanoparticles for imaging-guided combined photothermal and photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Ultrathin, bioresponsive and drug-functionalized protein capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Protein Capsules Assembled via Isobutyramide Grafts: Sequential Growth, Biofunctionalization, and Cellular Uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

On the binding of cinmetacin and indomethacin to human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201600038

21 January 2018

Identifiers

DOI

10.1002/ADMA.201600038

1 reference

7 September 2017

1 reference

PubMed ID

27111654